Optogenetic Therapy Partially Restores Vision in Blind Patient
Start here
Optics & Photonics News reports that an early clinical study showed optogenetic therapy can partially restore vision in patients with severe vision loss. Most adverse events were mild to moderate, with only one transient severe event after injection that resolved within minutes. First author José-Alain Sahel of the University of Pittsburgh said the results show that the visual system retains the ability to process new information even in people with severe blindness.
From Optics & Photonics News
Report timeline
Follow the reports to see the event from different angles.
- Optics & Photonics NewsPicksOptogenetic Therapy Partially Restores Vision in Early Clinical Study
Optics & Photonics News reports that an early clinical study showed optogenetic therapy can partially restore vision in patients with severe vision loss. Most adverse events were mild to moderate, with only one transient severe event after injection that resolved within minutes. First author José-Alain Sahel of the University of Pittsburgh said the results show that the visual system retains the ability to process new information even in people with severe blindness.